Lessons from Research Innovations in Depression and HIV in Low-and Middle-Income Countries

TY - CHAP

T1 - Lessons from Research Innovations in Depression and HIV in Low-and Middle-Income Countries

AU - Jopling, Rebecca

AU - Yang, Joyce P.

AU - Meffert, Susan

AU - Müller, Monika

AU - Nyamayaro, Primrose C.

AU - Abas, Melanie

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Antiretroviral therapy has transformed HIV into a manageable disease, preventing the progression of HIV to AIDS and improving quality of life for people living with HIV. Increasing the number of people who test for HIV, initiating people living with HIV on antiretroviral therapy, and supporting them to adhere to their regimen have become central goals to the global strategy to end AIDS by 2030. Although we have seen extraordinary achievements, we are not on track to achieve these goals. People living with HIV face considerable emotional and social challenges which are known to adversely impact on their capacity to engage fully with HIV care and to maintain adherence to HIV medication. Among formally diagnosed mental disorders in people living with HIV, depression has received the most attention. However, in many settings where HIV is endemic, there is no single word for depression and emotional responses may be seen as “weakness” and something to be hidden (Aggarwal et al., Int J Soc Psychiatr 62(2):198–200, 2016). Sub-Saharan Africa carries the highest burden of HIV and has limited numbers of trained mental health care professionals. This chapter describes the global challenges to reducing new infections and HIV related deaths and illustrates innovative ways in which depression can be treated alongside HIV to allow people living with HIV to benefit from antiretroviral therapy and maintain healthy survival.

AB - Antiretroviral therapy has transformed HIV into a manageable disease, preventing the progression of HIV to AIDS and improving quality of life for people living with HIV. Increasing the number of people who test for HIV, initiating people living with HIV on antiretroviral therapy, and supporting them to adhere to their regimen have become central goals to the global strategy to end AIDS by 2030. Although we have seen extraordinary achievements, we are not on track to achieve these goals. People living with HIV face considerable emotional and social challenges which are known to adversely impact on their capacity to engage fully with HIV care and to maintain adherence to HIV medication. Among formally diagnosed mental disorders in people living with HIV, depression has received the most attention. However, in many settings where HIV is endemic, there is no single word for depression and emotional responses may be seen as “weakness” and something to be hidden (Aggarwal et al., Int J Soc Psychiatr 62(2):198–200, 2016). Sub-Saharan Africa carries the highest burden of HIV and has limited numbers of trained mental health care professionals. This chapter describes the global challenges to reducing new infections and HIV related deaths and illustrates innovative ways in which depression can be treated alongside HIV to allow people living with HIV to benefit from antiretroviral therapy and maintain healthy survival.

UR - http://www.scopus.com/inward/record.url?scp=85161796845&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-57296-9_6

DO - 10.1007/978-3-030-57296-9_6

M3 - Chapter

AN - SCOPUS:85161796845

SN - 9783030572952

VL - 1

SP - 169

EP - 190

BT - Innovations in Global Mental Health

PB - Springer International Publishing

ER -